Predictors of distant relapse in patients with FIGO stage IIB-IVA cervical cancer treated with definitive radiotherapy

Author:

Okazawa-Sakai Mika12,Mabuchi Seiji2ORCID,Isohashi Fumiaki3,Kawashima Atsushi3,Yokoi Eriko2,Ogawa Kazuhiko3,Kimura Tadashi2

Affiliation:

1. Department of Gynecological Oncology; National Hospital Organization Shikoku Cancer Center; Matsuyama Japan

2. Department of Obstetrics and Gynecology; Osaka University Graduate School of Medicine; Suita Japan

3. Department of Radiation Oncology; Osaka University Graduate School of Medicine; Suita Japan

Publisher

Wiley

Subject

Obstetrics and Gynecology

Reference20 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

3. National Cancer Institute SEER Cancer Statistics Review 1975-2012 http://seer.cancer.gov/archive/csr/1975_2012/results_merged/sect_05_cervix_uteri.pdf

4. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer;Rose;N Engl J Med,1999

5. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis;Green;Lancet,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3